Home Newsfeeds Cowen & Co. Downgrades Graphite Bio to Market Perform

Cowen & Co. Downgrades Graphite Bio to Market Perform

Cowen & Co. analyst Phil Nadeau downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform.

byBenzinga Newsdesk

February 23, 2023

1 minute read

Cowen & Co. analyst Phil Nadeau downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform.

SEC Commissioner Declares ‘No Reason For Us To Stand In The Way’ Of Bitcoin ETF: Is Gary Gensler Listening?

By Murtuza Merchant

November 22, 5:32 PM

In the wake of crypto exchange Binance (CRYPTO: BNB) agreeing to a $4 billion settlement with the Justice Department, SEC Commissioner H

$BNB

Praxis Precision Medicines Provides Portfolio Update At 2023 R&D Day

By Benzinga Newsdesk

October 2, 1:22 PM

Positive results from preliminary analysis of PRAX-222 Part 1 showed 44% median reduction in seizures after three doses for SCN2A-gain-of-function pediatric patients Phase 3 (Essential3) program for ulixacaltamide

IONS

Donald Trump Exploring Second Presidential Run As ‘Get Out Of Jail Free’ Card: Reports

By Shivdeep Dhaliwal

July 5, 10:43 PM

Former President Donald Trump could announce an early presidential run to preempt attempts to prosecute him, according to multiple reports.

SPY

Fertilizer Stocks Rally As Israel Conflict Creates Potential Supply Disruption

By Piero Cingari

October 9, 5:09 PM

Fertilizer companies are witnessing a surge in their stock prices, driven by concerns over global nutrient supplies essential for food crops.

Cowen & Co. Downgrades Graphite Bio to Market Perform

Related Posts

SEC Commissioner Declares ‘No Reason For Us To Stand In The Way’ Of Bitcoin ETF: Is Gary Gensler Listening?

Praxis Precision Medicines Provides Portfolio Update At 2023 R&D Day

Donald Trump Exploring Second Presidential Run As ‘Get Out Of Jail Free’ Card: Reports

Fertilizer Stocks Rally As Israel Conflict Creates Potential Supply Disruption